A Case of Pathological Complete Remission for Colon Cancer with BRAF V600E Mutation and MSI-high Plus Multiple Metastasis by Pembrolizumab after Bevacizumab Plus FOLFOXIRI Therapy | Zendy

AI Assistant Blog Pricing

A Case of Pathological Complete Remission for Colon Cancer with <i>BRAF</i> V600E Mutation and MSI-high Plus Multiple Metastasis by Pembrolizumab after Bevacizumab Plus FOLFOXIRI Therapy

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.